Peritoneal Dialysis (PD) Specialized LLM for PD Management

NCT07539428 · tracked via the Priya Life Science China tracker

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Phase

Not applicable

Started

2026-04-05

Last updated

2026-04-20

Condition(s) studied

Peritoneal Dialysis (PD)Large Language Models

Investigational drug(s) / intervention(s)

Peritoneal dialysis-specialized large language model.Generalized LLM tools such as deepseek

Peritoneal dialysis-specialized large language model.: The peritoneal dialysis-specialized large language model (PD-LLM) used in this study was jointly developed by the Department of Nephrology at the First Affiliated Hospital of Sun Yat-sen University and Digital Health China (DHC).

Generalized LLM tools such as deepseek: Participants were permitted to ask the LLM any questions related to the clinical scenarios. However, they were explicitly instructed to critically evaluate the model's suggestions and to take full responsibility for the final clinical plans.

Study summary

This study conducted a randomized controlled trial using clinical vignettes to evaluate differences in the quality of PD management among two large language model-assisted workflows and a physician-only decision-making process, and to identify potential risks (e.g., generating clearly erroneous or even harmful suggestions).

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: 1. Internal medicine or nephrology standardized training residents, licensed residents, or attending physicians. 2. Independent experience in PD management ≤ 3 years. 3. Provided signed informed consent and agreed to comply with the trial procedures. Exclusion Criteria: 1. Direct involvement in the development or training of the specialized PD large language model, or in the construction of the clinical scenarios/ scoring criteria used in this trial. 2. Participation in the pilot testing of all clinical scenarios used in this trial. 3. Inability or unwillingness to access the study platform or use online resources during the study period. 4. Experienced PD experts.

Primary outcome measure(s)

Management Reasoning — Within 90-min study
Percent correct (range: 0 to 100) for each case.

Trial sites (1)

Facility	City	Region	Status
Sixiu Chen	Guangzhou	Guangdong

More First Affiliated Hospital, Sun Yat-Sen University trials in China

Intrathecal Morphine for Postoperative Analgesia in Major Laparoscopic Abdominal Surgery, a IMPACT-Scope Trial Recruiting

Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds Recruiting

Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD Starting soon

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy Recruiting

Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients Recruiting

Other trials for the same condition

A Multimodal AI Agent for Ophthalmic Clinical Decision Support Starting soon

Acute Myocardial Infarction Clinical Intelligent Decision Support System Active, not recruiting

Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine Active, not recruiting

Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients Enrolling by invitation

A Simulated Case Study of a Peritoneal Dialysis-Specialized Large Language Model Assisting Doctors in Improving Decision-Making in Peritoneal Dialysis Management Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07539428 on ClinicalTrials.gov ↗ ← All trials in China